Search Results

-positive (Ph+) marrow metaphases,” as they correspond to long-term outcomes such as progression-free and overall survival (OS). The treatment options recommended by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for chronic-phase CML

NCCN Evidence Blocks to Guide Decision-Making NCCN recently introduced NCCN Evidence Blocks into a number of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to assist clinicians and patients as they grapple with treatment

Africa (MENA) region is not completely known. A prostate cancer committee was established to modify the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Prostate Cancer for adaptation and implementation in the MENA region. The objective

The uses and distribution of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) continue to increase dramatically, with more than 3 million downloads from the NCCN Web site in 2010 alone. More than 230,000 individuals in 194

and includes a variety of regimen choices. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) endorse a number of anthracycline- and non-anthracycline–based options. Data in this figure are adapted from distribution data provided by

East and North Africa) region guideline committees began the process of modifying the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for several tumor types, including lymphoma. The MENA region includes Morocco, Algeria, Tunisia

Clinical Practice Guidelines in Oncology (NCCN Guidelines) from some of the members who were in the delivery room when they were born. For example, in 1996, the NCCN Guidelines for Lung Cancer were created by a 7-member lung cancer panel and included 40

Practice Guidelines in Oncology (NCCN Guidelines) for multiple myeloma regarding transplant candidates were updated to include this triplet as an initial treatment option under “other regimens.” This joins a growing list of triplets that greatly increase

. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Senior Adult Oncology include a comprehensive geriatric assessment that can be used to help predict the risk of toxicity from cancer treatment in older patients. Along with age

Overview T he NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer: Noninvasive and Special Situations presented here are the work of the NCCN Breast Cancer panel members. Categories of evidence and consensus were